| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure |
|
Advice You - Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure
Just as a competent medical practitioner needs to understand the causes of a disease, a
competent turnaround manager must understand the causes of the company According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ’s decline. Much like human beings, companies are perpetually faced with all kinds of viruses or threats to their health, some are internally created whilst ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in thers are externally generated.
The human body is always battling all these threats so as to maintain the equilibrium of
health or homeostasis. Likewise, an lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. organisation that is able to successfully address both
internal and external problems (from operational hiccups to market threats) will bound to
enjoy corp here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rate health and longevity. The troubled company usually gets attacked by two types of problems – internal and external viruses. Many of the internal viruses d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro are generated by the company and are actually within the
company’s control. They are usually associated with weak management and poor
financial system. The ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc onslaught of such viral attacks can lead to bad or untimely business
decisions, poor financial control and other related problems. The medical analogy for
e easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi liminating internal viruses may merit the use of surgery such as downsizing,
restructuring or change. For example a poll of the members of the Turnaround Man nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gement Association, people
whose job is to rescue troubled businesses revealed that while 22 percent of turnaround
professionals cited increased competition and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ as a reason for business failures, a full 58
percent squarely put the blame on faulty management decision-making. Similarly, other
studies have found that ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nternal, rather than external causes are behind up to 90 percent of
company failures. Peter Tourtellot, former chairman and now a turnaround manager
himself ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a noted that one of the most common mistakes was that troubled companies did not
listen to their customers. He also found that communication was sadly lacking i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n most of
the troubled businesses. Business journalist, Bruce G. Posner cited some of management’s most embarrassing mistake. “What kills companies,” he sa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d, “has less to do with insufficient money, talent,
or information than with something more basic: a shortage of good judgment and
understanding at the very tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen top.” External viruses being macro in nature are often beyond the company’s control. The entire industry or marketplace or even the whole country may be str t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel cken by the same
type of external viruses. The attacks can be silent, swift and often appear non-threatening
at the beginning. Examples of external viruses ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust include economic recession, change in
technology and consumer behaviour, political turmoil, natural disasters and terrorist
attacks. Such external viruses y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products re harder to eliminate and predict. Sometimes, even having a
strong management team is inadequate to cope with external viruses as the corporate
culture is . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de unable to manage change expediently. The remedy is to foster a strong and
healthy corporate culture that is the immune system of the company. Thus the best p elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ognosis is to identify the viruses, predict their potential damage and
eradicate them before they are able to penetrate, attack and wreak havoc to your system tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Accounting Business Outsource Process is a Good Approach Air Traffic Controller Employment Crisis Looming How to Pay a Powerful Compliment
|